Profarma Distribuidora de Produtos Farmacêuticos S.A. Stock
Equities
PFRM3
BRPFRMACNOR1
Drug Retailers
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.35 BRL | -9.63% | -9.31% | -12.13% |
Sales 2022 | 7.82B 1.51B | Sales 2023 | 8.66B 1.67B | Capitalization | 748M 145M |
---|---|---|---|---|---|
Net income 2022 | 80M 15.46M | Net income 2023 | 70M 13.53M | EV / Sales 2022 | 0.17 x |
Net Debt 2022 | 841M 163M | Net Debt 2023 | 950M 184M | EV / Sales 2023 | 0.2 x |
P/E ratio 2022 |
5.56
x | P/E ratio 2023 |
10.6
x | Employees | 7,077 |
Yield 2022 |
4.72% | Yield 2023 |
1.9% | Free-Float | 32.86% |
1 day | -9.46% | ||
1 week | -9.31% | ||
Current month | -6.94% | ||
1 month | -10.52% | ||
3 months | -6.62% | ||
6 months | +2.29% | ||
Current year | -12.13% |
Managers | Title | Age | Since |
---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 55 | 85-12-31 |
Director of Finance/CFO | 66 | 92-12-31 | |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 55 | 85-12-31 |
Founder | 89 | 61-04-30 | |
Carlos Gros
BRD | Director/Board Member | - | 20-06-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +4.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 5.35 | -9.63% | 91 500 |
24-05-24 | 5.45 | -3.71% | 183,400 |
24-05-23 | 5.66 | -0.53% | 245,000 |
24-05-22 | 5.69 | -4.21% | 227,500 |
24-05-21 | 5.94 | +0.51% | 174,100 |
Delayed Quote Sao Paulo, May 27, 2024 at 12:14 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-12.13% | 130M | |
-28.01% | 10.96B | |
+14.69% | 6.34B | |
-10.01% | 6.08B | |
-27.59% | 6.05B | |
+72.00% | 4.98B | |
-2.48% | 4.64B | |
-4.84% | 4B | |
-17.19% | 3.28B | |
-12.21% | 2.86B |
- Stock Market
- Equities
- PFRM3 Stock